Respir Res. 2026 Apr 14. doi: 10.1186/s12931-026-03613-6. Online ahead of print.
NO ABSTRACT
PMID:41981420 | DOI:10.1186/s12931-026-03613-6
Categories
Elarekibep, an inhaled anti-IL-4 receptor alpha Anticalin, in moderate-to-severe asthma: a randomized, placebo-controlled phase 2a study (APATURA)
